Study finds AI blood test developed at Johns Hopkins successfully detects liver cancer

American College of Radiology approves first ever Practice Parameter for Imaging Artificial Intelligence

The American College of Radiology Council approved the ACR-SIIM (Society for Imaging Informatics in Medicine) Practice Parameter for Imaging Artificial Intelligence at ACR 2026, the College’s annual meeting in Washington, DC.

May 08, 2026

Vol.52 No.18

Clinical Roundup

Hopkins physicians achieve 95% cure rate for sickle cell disease with bone marrow transplant

A reduced-intensity bone marrow transplant regimen provides durable engraftment with low rejection rates and also may preserve fertility, according to researchers at Johns Hopkins Kimmel Cancer Center.

May 08, 2026

Vol.52 No.18

Clinical Roundup

Inherited long telomeres may drive broad risk for lymphoid cancers, Hopkins-led study finds

Researchers at the Johns Hopkins Kimmel Cancer Center have identified a genetic syndrome in which unusually long telomeres—the protective caps at the ends of chromosomes—allow immune cells to remain biologically “younger” for longer than normal, predisposing affected individuals to lymphoma and other cancers.

May 08, 2026

Vol.52 No.18

Cancer Policy

CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, or ACIP, voted in December to rescind its recommendation that all newborns receive a hepatitis B virus vaccine dose within 24 hours of birth.

May 01, 2026

Vol.52 No.17

By Claire Marie Porter

Clinical Roundup

Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds

A Mayo Clinic has developed an artificial intelligence model that can help specialists detect pancreatic cancer on routine abdominal CT scans up to three years before clinical diagnosis. It identifies subtle signs of disease before tumors are visible, when curative treatment may still be possible.

May 01, 2026

Vol.52 No.17

Drugs & Targets

Unfold AI’s prostate cancer mapping added to regional CMS Physician Fee Schedule

Unfold AI, an AI prostate cancer mapping and clinical decision support platform, is now included in Medicare’s Physician Fee Schedules across the West Coast and Mountain West regions. The regional expansion of Medicare payment for the tool gives urologists and care teams clearer reimbursement pathways in physician office settings, an area that has historically lagged behind hospital outpatient settings for emerging technologies.

May 01, 2026

Vol.52 No.17

Study finds AI blood test developed at Johns Hopkins successfully detects liver cancer

YOU MAY BE INTERESTED IN

American College of Radiology approves first ever Practice Parameter for Imaging Artificial Intelligence

Hopkins physicians achieve 95% cure rate for sickle cell disease with bone marrow transplant

Inherited long telomeres may drive broad risk for lymphoid cancers, Hopkins-led study finds

CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show

Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds

Unfold AI’s prostate cancer mapping added to regional CMS Physician Fee Schedule

Renew today!

Subscriber content

Never miss an issue!

Login